Research to Prevent Blindness (RPB) provides major eye research funding to 40 leading scientific institutions in the U.S. and supports the work of hundreds of talented vision scientists engaged in a diverse range of disease-oriented research.
Recent grants include funding for an international collaboration, as well as a wide variety of U.S.- based eye research.
An RPB Trustee pens a powerful Op-Ed on the need to support scientific research through the National Institutes of Health.
With deep sorrow, Research to Prevent Blindness (RPB) announces the passing of John I. Bloomberg, who served on the RPB Board of Trustees from 2007 to 2017.
The latest grant cycle supports eye research related to a variety of diseases and conditions.
RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice.
Twenty-two emerging vision scientists conducted Capitol Hill visits with NAEVR and RPB to champion federal funding for critical vision research.
A common pathway involved in photoreceptor death has been identified in retinitis pigmentosa, advanced dry age-related macular degeneration and other retinal diseases, with early evidence of a possible halt to vision loss related to pathway treatment.
Research initiative to address urgent needs in understanding and treating low vision.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|